Sinsan Pharmaceuticals
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimfirst MV 2 Tablet ER is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels.
Tablet ER
Glimfirst MV 2 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medication should be taken with food to avoid an upset stomach and can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if a meal is delayed or missed. Regular liver function checks may be necessary, and any symptoms like abdominal pain, loss of appetite, or jaundice should be reported to a doctor. It is important to follow the prescribed dosage and duration as advised by a healthcare professional.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimfirst MV 2 Tablet ER is to be taken on an empty stomach.
Glimfirst MV 2 Tablet ER is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimfirst MV 2 Tablet ER is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, along with a healthy diet and regular exercise, to improve blood glucose levels. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose reduces postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Glimfirst MV 2 Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare professional for guidance.
Glimfirst MV 2 Tablet ER should be avoided in patients with known allergies to its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis. Consult your doctor or healthcare professional before taking this medication if you have any of these conditions.
No, it is not recommended to consume alcohol while taking Glimfirst MV 2 Tablet ER. This combination may increase the risk of hypoglycemia and lactic acidosis. It is essential to follow your doctor's advice on alcohol consumption while taking this medication.
Yes, Glimfirst MV 2 Tablet ER can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This condition is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitoring your blood sugar levels is crucial, and it is recommended to keep glucose tablets, honey, or fruit juice with you at all times.
Store Glimfirst MV 2 Tablet ER in its original packaging, tightly closed, according to the instructions on the pack or label. Dispose of any unused medication properly, ensuring it is not consumed by pets, children, or other individuals.